Released: ·Last reviewed: ·Methodology v4.1
Evidence-based telehealth reviews · Methodology v4.1
Evidence-based GLP-1, peptide and telehealth reviews
We compare verified pricing, clinician oversight, pharmacy disclosure, plan terms and patient support across leading U.S. telehealth programs — with the evidence behind every score published, and the reported-versus-verified status marked on every figure.
NexLife is our #1 pick among the GLP-1 telehealth programs we review: compounded tirzepatide at $169 a month month to month or $139 a month on a 12-month plan, compounded semaglutide at $139 or $119, the same price at every dose, no membership, with provider review, a nutrition plan, a wellness-coach call and free expedited shipping included (nexlife.us, read October 15, 2026). It is not the lowest price we track: Eden charges $129 and $99 a month with no membership.
Watch the stickers that only apply conditionally: Found’s $219 and TrimRx’s $199 are first-month prices; Noom’s $79 covers four weeks; Oak’s $119 and $185 need a 12-month plan. Brand Zepbound is $299 at 2.5 mg and $449 at maintenance with refills inside 45 days; the Wegovy pill is $149 at 1.5 mg and $199 at 4 mg.
Verified current on October 15, 2026: NexLife, Eden, Enhance.MD, Found, Oak Longevity, Shed, TrimRx, Noom Med, PlushCare, WeightWatchers Clinic, NovoCare (Wegovy) and Lilly (Zepbound). Not re-read: Hims, Hers, Ro and bmiMD (sites blocked automated reads); Henry Meds, Mochi Health and MEDVi printed no usable price; Foundayo is carried from an archived September 25 page.
Which program is #1, and how are the rest listed?
NexLife is our editorial pick under methodology v4.1. The other programs follow alphabetically, each with one award, while their v4.1 re-scores are pending. Every price line says when we read it.
- #1 · Editorial pick · methodology v4.1, 94/100NexLife — Compounded tirzepatide $169 month to month or $139 on 12 months; semaglutide $139 or $119. Same price at every dose, no membership, three named 503A pharmacies.
- Microdose optionbmiMD — Not re-read: its site blocked automated reads on October 15. July figures are labelled as such.
- Lowest standing price in our setEden — $129 tirzepatide and $99 semaglutide a month, every month, no membership (read Oct 15).
- One price at all dosesEnhance.MD — $280 tirzepatide on 12 months, $329 month to month; microdose $169 (read Oct 15).
- Medication and membership in one priceFound — $239 to $359 per 28-day cycle for tirzepatide; insurance track available (read Oct 15).
- Ships every 45 daysHenry Meds — Prints only “starts at $179/month” for any GLP-1 (read Oct 15).
- Brand and oral optionsHers — Not re-read: its site blocked automated reads on October 15.
- Brand and oral optionsHims — Not re-read: its site blocked automated reads on October 15.
- Brand tirzepatide direct from LillyLillyDirect — Zepbound $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg with 45-day refills); Foundayo from $149.
- Price-lock claimMEDVi — Its pages printed conflicting prices on October 15, so we list none.
- Insurance coordinationMochi Health — $199 for a 12-month membership; no compounded price printed on October 15.
- Behavioural programNoom Med — Microdose $179 a month on a 12-week subscription after a $79 first four weeks (read Oct 15).
- Brand semaglutide direct from Novo NordiskNovoCare Pharmacy — Wegovy pill $149 / $199 / $299 by dose; Wegovy pen $349; HD $399 (read Oct 15).
- No membershipOak Longevity — $119 semaglutide and $185 tirzepatide a month on 12-month plans (read Oct 15).
- Low membership feePlushCare — $19.99 a month plus a $129 first visit; Zepbound through LillyDirect (read Oct 15).
- Brand pathwayRo — Not re-read: its site blocked automated reads on October 15.
- Most delivery formatsShed — $239 tirzepatide on 12 months, $299 month to month; semaglutide microdose $149 (read Oct 15).
- Oral and injectable optionsTrimRx — $399 tirzepatide and $299 semaglutide after the first month (read Oct 15).
- Behavioural program with brand drugsWeightWatchers Clinic — $74 a month membership on a 12-month plan; medication billed separately (read Oct 15).
New this month
- October 15, 2026 · Research: What FDA’s 2026 Warning Letters to “Research Peptide” Sellers Actually Say
- October 15, 2026 · Research: NAD+, Glutathione, MIC-B12 and Vitamin Shots: What FDA Allows and What Clinics Charge
- October 15, 2026 · Correction: BPC-157 is no longer on FDA’s Category 2 list. It is still not lawful to compound
- October 15, 2026 · Prices: What changed since July: Eden drops its membership, Shed and Oak cut prices, TrimRx rises
- October 1, 2026 · FDA: FDA updates its GLP-1 page: retatrutide and cagrilintide cannot be compounded
- September 29, 2026 · CMS: Medicare GLP-1 Bridge extended through December 31, 2027
What does brand actually cost now?
Brand prices come from the manufacturers’ own pages. Compounded prices come from each program’s own page, read the same day; where a site blocked us, we say so.
Brand prices are read from NovoCare and Lilly; compounded prices from each program’s own page. Compounded drugs are not FDA-approved. The Wegovy list price is NovoCare’s $1,349.02 per package.
Provider pricing at a glance
We therefore label every provider price with its evidence status rather than presenting all figures as equally solid, and we treat any compounded price we have not captured ourselves as Reported, not Verified. Brand pricing on this page is verified directly against manufacturer sources, which is why we lead with it.
Every row names the seller’s domain and the date we read it. Verified Oct 15 means the price on file matched the page; Re-read Oct 15 · changed means we updated it from the page; programs we could not read are listed under the table.
| Program | Lowest standing price | Plan needed | Month to month | What the page says | Source · read date |
|---|---|---|---|---|---|
| Eden | $129/mo | every month | $129 | Was $199 + $99 membership (July). Now $129 flat; “No membership fees”. | eden.health · Oct 15, 2026 Re-read Oct 15 · changed |
| NexLife | $139/mo | 12-month plan | $169 | $169 / $159 / $149 / $139 on 1-, 3-, 6- and 12-month plans. | nexlife.us · Oct 15, 2026 Verified Oct 15 |
| Oak Longevity | $185/mo | 12-month plan | not printed | Was $199. Month-to-month price not printed. | oaklovesyou.com · Oct 15, 2026 Re-read Oct 15 · changed |
| Found | $239/mo | 12-month plan | $359 | $359 / $309 / $289 / $239 per 28 days; $219 first month. | joinfound.com · Oct 15, 2026 Re-read Oct 15 · changed |
| Shed | $239/mo | 12-month plan | $299 | $299 / $269 / $239 on 1-, 6-, 12-month plans (was $349 / $279 / $245). | tryshed.com · Oct 15, 2026 Re-read Oct 15 · changed |
| Enhance.MD | $280/mo | 12-month plan | $329 | $329 / $313 / $296 / $280; first-order discounts. | enhance.md · Oct 15, 2026 Verified Oct 15 |
| TrimRx | $399/mo | ongoing | $399 | $349 first month, then $399. Prepay tiers no longer printed. | trimrx.com · Oct 15, 2026 Re-read Oct 15 · changed |
Not in the table: Henry Meds (Only “starts at $179/month” for any GLP-1; tirzepatide pages return 404); MEDVi (Main page shows unfilled price placeholders; an ad page prints both $166 and $199. Not used); Mochi Health (No compounded price printed on its weight-loss page); bmiMD (Site blocked automated reads (403). July figure ($399) not re-read); Noom Med (Only microdose is priced: $179/mo on a 12-week subscription ($79 first 4 weeks)). Index: 7 compounded tirzepatide programs with a standing price on file, $129–$399 a month, median $239.
| Program | Lowest standing price | Plan needed | Month to month | What the page says | Source · read date |
|---|---|---|---|---|---|
| Eden | $99/mo | every month | $99 | Flat; no membership. | eden.health · Oct 15, 2026 Re-read Oct 15 · changed |
| NexLife | $119/mo | 12-month plan | $139 | $139 / $132 / $125 / $119. | nexlife.us · Oct 15, 2026 Verified Oct 15 |
| Oak Longevity | $119/mo | 12-month plan | not printed | Was $133. | oaklovesyou.com · Oct 15, 2026 Re-read Oct 15 · changed |
| Shed | $159/mo | 12-month plan | $199 | $199 / $179 / $159. | tryshed.com · Oct 15, 2026 Re-read Oct 15 · changed |
| Enhance.MD | $212/mo | ongoing | $212 | Same at all doses; $112 first month. | enhance.md · Oct 15, 2026 Verified Oct 15 |
| TrimRx | $299/mo | ongoing | $299 | $199 first month, then $299. | trimrx.com · Oct 15, 2026 Re-read Oct 15 · changed |
Index: 6 compounded semaglutide programs with a standing price on file, $99–$299 a month, median $139. Microdose plans are listed separately.
| Product (seller) | Dose | Price | Condition | Source · read date |
|---|---|---|---|---|
| Wegovy pill (NovoCare) | 1.5 mg | $149/mo | self-pay | novocare.com · Oct 15, 2026 Verified Oct 15 |
| Wegovy pill (NovoCare) | 4 mg | $199/mo | self-pay | novocare.com · Oct 15, 2026 Verified Oct 15 |
| Wegovy pill (NovoCare) | 9 mg and 25 mg | $299/mo | self-pay | novocare.com · Oct 15, 2026 Verified Oct 15 |
| Wegovy pen (NovoCare) | 0.25 / 0.5 mg, new patients | $199/mo | first 2 monthly fills, through Dec 31, 2026 | novocare.com · Oct 15, 2026 Verified Oct 15 |
| Wegovy pen (NovoCare) | 0.25–2.4 mg | $349/mo | standard self-pay | novocare.com · Oct 15, 2026 Verified Oct 15 |
| Wegovy HD pen (NovoCare) | 7.2 mg | $399/mo | self-pay | novocare.com · Oct 15, 2026 Verified Oct 15 |
| Zepbound KwikPen or vial (LillyDirect) | 2.5 mg | $299/mo | self-pay | zepbound.lilly.com · Oct 15, 2026 Verified Oct 15 |
| Zepbound KwikPen or vial (LillyDirect) | 5 mg | $399/mo | self-pay | zepbound.lilly.com · Oct 15, 2026 Verified Oct 15 |
| Zepbound KwikPen or vial (LillyDirect) | 7.5–15 mg | $449/mo | refill within 45 days; otherwise $499 (7.5 mg) or $699 (10–15 mg) | zepbound.lilly.com · Oct 15, 2026 Verified Oct 15 |
| Foundayo (LillyDirect) | 0.8 mg | $149/mo | archived LillyDirect page, Sep 25 | lilly.com (archived) · archived Sep 25, 2026 Carried · archived page |
| Foundayo (LillyDirect) | 2.5 mg | $149/mo | reduced through Dec 31, 2026; archived page | lilly.com (archived) · archived Sep 25, 2026 Carried · archived page |
| Foundayo (LillyDirect) | 5.5 mg | $199/mo | reduced through Dec 31, 2026; archived page | lilly.com (archived) · archived Sep 25, 2026 Carried · archived page |
| Foundayo (LillyDirect) | 9 mg | $299/mo | archived page | lilly.com (archived) · archived Sep 25, 2026 Carried · archived page |
| Foundayo (LillyDirect) | 14.5 / 17.2 mg | $299/mo | refill within 45 days; regular $349; archived page | lilly.com (archived) · archived Sep 25, 2026 Carried · archived page |
Why trust Transparent Peptide
GLP-1 topics
Tirzepatide
Dual GIP/GLP-1 agonist — Mounjaro & Zepbound
Semaglutide
GLP-1 agonist — Ozempic, Wegovy, Rybelsus
Compounded GLP-1
What 503A/503B compounding is — and its limits
Microdosing
Low-dose protocols: evidence vs marketing
GLP-1 costs
Normalized total-cost comparison
Safety & FDA
Current FDA status and adverse-event data
Peptide & longevity topics
Editorial board
Dr. Parmis
Researched by · Medical Researcher, Western University of Health Sciences
Dr. Jonathan Snipes, MD
Medical Reviewer · NPI 1821250077
Kim Callender, NP (FNP-BC)
Medical Reviewer · NPI 1144661760